Altered trafficking of mutated growth factor receptors and their associated molecules: implication for human cancers
Shunsuke Kon1, Nobuhide Kobayashi1, Masanobu Satake1
1Institute of Development, Aging and Cancer, Tohoku University; Sendai, Japan.
Abstract:
Ligand-stimulated receptor tyrosine kinases (RTKs) are phosphorylated/ubiquitinated, endocytosed and transported to the lysosomes via endosomes/multivesicular bodies, resulting in the attenuation of signal transmission. If this physiological mechanism of RTK signal downregulation is perturbed, signal transduction persists and may contribute to cellular transformation. This article presents several such examples. In some cases, endocytosis is impaired, and the activated RTK remains on the plasma membrane. In other cases, the activated RTK is endocytosed into endosomes/multivesicular bodies, but not subsequently sorted to the lysosomes for degradation. The latter cases indicate that even endocytosed RTKs can transmit signals. Transport of RTKs is accomplished via the formation and movement of membrane vesicles. Blockage or delay of endocytosis/trafficking can be caused by genetic alterations in the RTK itself or by mutations in CBL, Arf GAPs, or other components involved in internalization and vesicle transport. A survey of the literature indicates that, in some cases, even RTKs synthesized de novo can initiate signaling at the endoplasmic reticulum/Golgi before reaching the plasma membrane. The spectrum of molecules targeted by the signal is likely to be different between cell surface- and endoplasmic reticulum/Golgi-localized RTKs.
Insights
Dysregulation of receptor tyrosine kinases (RTKs) signaling, due to impaired endocytosis or lysosomal trafficking, can lead to persistent signaling and cellular transformation. This review highlights examples of perturbed RTK downregulation mechanisms contributing to disease.
Area of Science:
- Cell Biology
- Molecular Biology
- Oncology
Background:
- Ligand-stimulated receptor tyrosine kinases (RTKs) are crucial signaling molecules involved in cellular communication.
- Proper downregulation of RTK signaling, through endocytosis and lysosomal degradation, is essential for preventing aberrant cell growth.
- Perturbations in RTK trafficking pathways can disrupt signal attenuation, leading to sustained signaling.
Purpose of the Study:
- To review and present examples of perturbed RTK signal downregulation mechanisms.
- To illustrate how defects in endocytosis and lysosomal transport of RTKs contribute to cellular transformation.
- To explore the consequences of RTK signaling initiated at the endoplasmic reticulum/Golgi.
Main Methods:
- Literature survey and review of existing studies on RTK signaling and trafficking.
- Analysis of genetic alterations in RTKs, CBL, Arf GAPs, and other trafficking components.
- Examination of RTK signaling initiated at intracellular compartments like the endoplasmic reticulum/Golgi.
Main Results:
- Impaired endocytosis can lead to activated RTKs persisting on the plasma membrane, prolonging signaling.
- Defective lysosomal sorting of endocytosed RTKs allows for continued signal transmission from endosomes/multivesicular bodies.
- RTKs can initiate signaling at the endoplasmic reticulum/Golgi before reaching the plasma membrane, with potentially different downstream targets.
Conclusions:
- Perturbations in the physiological downregulation of RTK signaling are implicated in cellular transformation and disease.
- Both impaired internalization and defective intracellular trafficking of RTKs can lead to persistent oncogenic signaling.
- The cellular localization of RTK signaling (cell surface vs. intracellular compartments) influences the spectrum of targeted molecules.
More Related Videos
09:52A Mimic of the Tumor Microenvironment: A Simple Method for Generating Enriched Cell Populations and Investigating Intercellular Communication
Published on: September 20, 2016
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Related Concept Videos
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Abnormal Proliferation
